Presentation Information

[F2-34]Establishment of guidelines for designing useful vaccine antigens and production of new COVID-19 vaccine antigen

*Takuya Hemmi1, Takao Hashiguchi1 (1. Institute for Life and Medical Sciences, Kyoto University (Japan))

Login required to view


Comment

To browse or post comments, you must log in.Log in